These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34572957)

  • 1. HPV Status as Prognostic Biomarker in Head and Neck Cancer-Which Method Fits the Best for Outcome Prediction?
    Kühn JP; Schmid W; Körner S; Bochen F; Wemmert S; Rimbach H; Smola S; Radosa JC; Wagner M; Morris LGT; Bozzato V; Bozzato A; Schick B; Linxweiler M
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a combined triple method to detect causative HPV in oral and oropharyngeal squamous cell carcinomas: p16 Immunohistochemistry, Consensus PCR HPV-DNA, and In Situ Hybridization.
    Pannone G; Rodolico V; Santoro A; Lo Muzio L; Franco R; Botti G; Aquino G; Pedicillo MC; Cagiano S; Campisi G; Rubini C; Papagerakis S; De Rosa G; Tornesello ML; Buonaguro FM; Staibano S; Bufo P
    Infect Agent Cancer; 2012 Feb; 7():4. PubMed ID: 22376902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inclusion of an E7 DNA Amplification Test Improves the Robustness of Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma Diagnosis.
    Perera PY; Perera LP; Filkoski L; Chen W; Lichy JH; Paal E; Maxwell JH
    World J Oncol; 2020 Feb; 11(1):1-8. PubMed ID: 32095184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive evaluation of human papillomavirus positive status and p16INK4a overexpression as a prognostic biomarker in head and neck squamous cell carcinoma.
    Deng Z; Hasegawa M; Aoki K; Matayoshi S; Kiyuna A; Yamashita Y; Uehara T; Agena S; Maeda H; Xie M; Suzuki M
    Int J Oncol; 2014 Jul; 45(1):67-76. PubMed ID: 24820457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p16 overexpression identifies oncogenic high-risk HPV infection in non-oropharyngeal squamous cell carcinoma of the head and neck.
    Becker AS; Merkel J; Bozkurt I; Strüder DF; Maletzki C; Hühns M; Zimpfer AH
    Head Neck; 2024 Apr; ():. PubMed ID: 38594829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the Prevalence of Human Papillomavirus (HPV) in Head and Neck Squamous Cell Cancers by Sex, Race, Anatomic Tumor Site, and HPV Detection Method.
    D'Souza G; Westra WH; Wang SJ; van Zante A; Wentz A; Kluz N; Rettig E; Ryan WR; Ha PK; Kang H; Bishop J; Quon H; Kiess AP; Richmon JD; Eisele DW; Fakhry C
    JAMA Oncol; 2017 Feb; 3(2):169-177. PubMed ID: 27930766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low prevalence of p16-positive HPV-related head-neck cancers in Thailand: tertiary referral center experience.
    Nopmaneepaisarn T; Tangjaturonrasme N; Rawangban W; Vinayanuwattikun C; Keelawat S; Bychkov A
    BMC Cancer; 2019 Nov; 19(1):1050. PubMed ID: 31694600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of p16 as a surrogate marker for transcriptionally active human papillomavirus status of oropharyngeal squamous cell carcinoma in an eastern Chinese population.
    Xu S; Sun B; Zhou R; Shi C; Han Y; Li J; Sun J; Tian Z; Zhang Z; Li J
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Mar; 129(3):236-245.e2. PubMed ID: 31987673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma.
    Chung CH; Zhang Q; Kong CS; Harris J; Fertig EJ; Harari PM; Wang D; Redmond KP; Shenouda G; Trotti A; Raben D; Gillison ML; Jordan RC; Le QT
    J Clin Oncol; 2014 Dec; 32(35):3930-8. PubMed ID: 25267748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined P16 and human papillomavirus testing predicts head and neck cancer survival.
    Salazar CR; Anayannis N; Smith RV; Wang Y; Haigentz M; Garg M; Schiff BA; Kawachi N; Elman J; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF
    Int J Cancer; 2014 Nov; 135(10):2404-12. PubMed ID: 24706381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasensitive detection of oncogenic human papillomavirus in oropharyngeal tissue swabs.
    Isaac A; Kostiuk M; Zhang H; Lindsay C; Makki F; O'Connell DA; Harris JR; Cote DW; Seikaly H; Biron VL
    J Otolaryngol Head Neck Surg; 2017 Jan; 46(1):5. PubMed ID: 28088212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of p16
    Prigge ES; Arbyn M; von Knebel Doeberitz M; Reuschenbach M
    Int J Cancer; 2017 Mar; 140(5):1186-1198. PubMed ID: 27859245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
    Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
    J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oropharyngeal squamous cell carcinoma: p16/p53 immunohistochemistry as a strong predictor of HPV tumour status.
    Benzerdjeb N; Tantot J; Blanchet C; Philouze P; Mekki Y; Lopez J; Devouassoux-Shisheboran M
    Histopathology; 2021 Sep; 79(3):381-390. PubMed ID: 33560536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of p16 immunohistochemistry and increased sensitivity of RNA in situ hybridization in cytology specimens of HPV-related head and neck squamous cell carcinoma.
    Wong KS; Krane JF; Jo VY
    Cancer Cytopathol; 2019 Oct; 127(10):632-642. PubMed ID: 31509355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Papillomavirus DNA Detection by Droplet Digital PCR in Formalin-Fixed Paraffin-Embedded Tumor Tissue from Oropharyngeal Squamous Cell Carcinoma Patients.
    Schiavetto CM; de Abreu PM; von Zeidler SV; de Jesus LM; Carvalho RS; Cirino MT; Carloni AC; Oliveira C; Scapulatempo-Neto C; de Almeida GC; de Menezes NS; Carvalho AL; Reis RM; de Carvalho AC
    Mol Diagn Ther; 2021 Jan; 25(1):59-70. PubMed ID: 33245553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating of HPV-DNA ISH as an adjunct to p16 testing in oropharyngeal cancer.
    Chi J; Preeshagul IR; Sheikh-Fayyaz S; Teckie S; Kohn N; Ziemba Y; Laser A; Frank D; Ghaly M; Kamdar D; Kraus D; Paul D; Seetharamu N
    Future Sci OA; 2020 Aug; 6(9):FSO606. PubMed ID: 33235805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pRb and CyclinD1 Complement p16 as Immunohistochemical Surrogate Markers of HPV Infection in Head and Neck Cancer.
    Dreyer JH; Hauck F; Barros MHM; Niedobitek G
    Appl Immunohistochem Mol Morphol; 2017; 25(5):366-373. PubMed ID: 26657876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
    Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
    Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.